In addition, from the epigenomic perspective, we found that LOC101928222 synergized with IGF2BP1 to stabilize HMGCS2 mRNA via a METTL16-mediated m6A-dependent pathway, leading to an increase in cholesterol synthesis, which consequently promoted CRC development. The gene discussed is METTL16; the disease is colorectal carcinoma.